StockNews.com Initiates Coverage on ObsEva (NASDAQ:OBSV)

Equities researchers at StockNews.com started coverage on shares of ObsEva (NASDAQ:OBSV) in a research report issued on Wednesday. The firm set a “hold” rating on the stock.

ObsEva Stock Down 100.0 %

The company has a market capitalization of $7.94 million, a PE ratio of -0.11 and a beta of 0.68. ObsEva has a one year low of $0.08 and a one year high of $2.14.

ObsEva Company Profile

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women’s reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.